Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Reimann

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Lancet. Infectious Diseases|July 31, 2021
Pathogen-free diagnosis of tuberculosisJan Heyckendorf, Maja Reimann, Sebastian Marwitz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2024
(Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic reviewThomas Theo Brehm, Maja Reimann, Niklas Köhler, et al.
Plos One|September 21, 2020
Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysisChristoph Jünger, Maja Reimann, Lenka Krabbe, et al.
Tuberculosis (Edinburgh, Scotland)|March 6, 2025
A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosisKatharina Budde, Christoph Lange, Maja Reimann, et al.
Plos One|February 19, 2021
Correction: Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysisChristoph Jünger, Maja Reimann, Lenka Krabbe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2023
Long-term treatment outcomes in patients with multidrug-resistant tuberculosisChristina Maier, Dumitru Chesov, Dagmar Schaub, et al.
Emerging Infectious Diseases|March 2, 2025
Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023Olha Konstantynovska, Tetiana Synenko, Alla Honcharenko, et al.
Respiration; International Review of Thoracic Diseases|May 31, 2021
Defining Outcomes of Tuberculosis (Treatment): From the Past to the FutureGunar Günther, Jan Heyckendorf, Jean Pierre Zellweger, et al.
The European Respiratory Journal|December 18, 2020
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden countryDumitru Chesov, Jan Heyckendorf, Sofia Alexandru, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 25, 2020
Changes in taste and smell as an early marker for COVID-19Mareike Luethgen, Johanna Eggeling, Jan Heyckendorf, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Lancet. Infectious Diseases|July 31, 2021
Pathogen-free diagnosis of tuberculosisJan Heyckendorf, Maja Reimann, Sebastian Marwitz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2024
(Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic reviewThomas Theo Brehm, Maja Reimann, Niklas Köhler, et al.
Plos One|September 21, 2020
Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysisChristoph Jünger, Maja Reimann, Lenka Krabbe, et al.
Tuberculosis (Edinburgh, Scotland)|March 6, 2025
A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosisKatharina Budde, Christoph Lange, Maja Reimann, et al.
Plos One|February 19, 2021
Correction: Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysisChristoph Jünger, Maja Reimann, Lenka Krabbe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2023
Long-term treatment outcomes in patients with multidrug-resistant tuberculosisChristina Maier, Dumitru Chesov, Dagmar Schaub, et al.
Emerging Infectious Diseases|March 2, 2025
Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023Olha Konstantynovska, Tetiana Synenko, Alla Honcharenko, et al.
Respiration; International Review of Thoracic Diseases|May 31, 2021
Defining Outcomes of Tuberculosis (Treatment): From the Past to the FutureGunar Günther, Jan Heyckendorf, Jean Pierre Zellweger, et al.
The European Respiratory Journal|December 18, 2020
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden countryDumitru Chesov, Jan Heyckendorf, Sofia Alexandru, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 25, 2020
Changes in taste and smell as an early marker for COVID-19Mareike Luethgen, Johanna Eggeling, Jan Heyckendorf, et al.
Pageof 4